10-Q Filing

IDEXX LABORATORIES INC /DE CIK: 874716 Q3 2016

Filing Information

Form Type	10-Q
Accession Number	`0000874716-16-000034`
Period End Date	20160930
Filing Date	20161101
Fiscal Year	2016
Fiscal Period	Q3
XBRL Instance	c716-20160930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 83 Income Statement 91 Cash Flow Statement 68 Comprehensive Income 56

Balance Sheet 83 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, reserves	`AllowanceForDoubtfulAccountsReceivableCurrent`	$5.13M	USD	Point-in-time
Accounts receivable, reserves	`AllowanceForDoubtfulAccountsReceivableCurrent`	$5.05M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$150.07M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	120.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	120.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$141.15M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$128.99M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$322.54M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	102.24M	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$213.59M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	103.12M	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$241.40M	USD	Point-in-time
Deferred stock units, outstanding	`CommonStockOtherSharesOutstanding`	231,000.00	shares	Point-in-time
Accounts receivable, net of reserves of $5,054 in 2016 and $5,128 in 2015	`AccountsReceivableNetCurrent`	$188.32M	USD	Point-in-time
Deferred stock units, outstanding	`CommonStockOtherSharesOutstanding`	240,000.00	shares	Point-in-time
Accounts receivable, net of reserves of $5,054 in 2016 and $5,128 in 2015	`AccountsReceivableNetCurrent`	$204.70M	USD	Point-in-time
Inventories	`InventoryNet`	$188.83M	USD	Point-in-time
Inventories	`InventoryNet`	$168.47M	USD	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	12.24M	shares	Point-in-time
Treasury stock, shares	`TreasuryStockShares`	13.41M	shares	Point-in-time
Deferred income tax assets	`DeferredTaxAssetsNetCurrent`	$39.83M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$63.46M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$62.07M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$821.63M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$828.10M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$349.66M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$333.03M	USD	Point-in-time
Goodwill	`Goodwill`	$178.93M	USD	Point-in-time
Goodwill	`Goodwill`	$180.95M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$47.57M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$55.91M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$85.49M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$94.09M	USD	Point-in-time
Total long-term assets	`AssetsNoncurrent`	$672.27M	USD	Point-in-time
Total long-term assets	`AssetsNoncurrent`	$653.36M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.47B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$1.50B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$44.13M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$52.65M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$202.07M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$205.53M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$488.00M	USD	Point-in-time
Line of credit	`LinesOfCreditCurrent`	$573.00M	USD	Point-in-time
Current portion of deferred revenue	`DeferredRevenueCurrent`	$25.58M	USD	Point-in-time
Current portion of deferred revenue	`DeferredRevenueCurrent`	$26.01M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$760.21M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$856.76M	USD	Point-in-time
Deferred income tax liabilities	`DeferredTaxLiabilitiesNoncurrent`	$49.39M	USD	Point-in-time
Deferred income tax liabilities	`DeferredTaxLiabilitiesNoncurrent`	$20.57M	USD	Point-in-time
Long-term debt	`SecuredLongTermDebt`	$597.09M	USD	Point-in-time
Long-term debt	`SecuredLongTermDebt`	$599.14M	USD	Point-in-time
Long-term deferred revenue, net of current portion	`DeferredRevenueNoncurrent`	$27.05M	USD	Point-in-time
Long-term deferred revenue, net of current portion	`DeferredRevenueNoncurrent`	$30.87M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$34.59M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$28.70M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$685.18M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$702.23M	USD	Point-in-time
Total liabilities	`Liabilities`	$1.56B	USD	Point-in-time
Total liabilities	`Liabilities`	$1.45B	USD	Point-in-time
Commitments and Contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 103,120 and 102,237 shares in 2016 and 2015, respectively	`CommonStockValue`	$10.31M	USD	Point-in-time
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 103,120 and 102,237 shares in 2016 and 2015, respectively	`CommonStockValue`	$10.26M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$994.30M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$940.53M	USD	Point-in-time
Deferred stock units: Outstanding: 231 and 240 units in 2016 and 2015, respectively	`CommonStockOtherValueOutstanding`	$5.41M	USD	Point-in-time
Deferred stock units: Outstanding: 231 and 240 units in 2016 and 2015, respectively	`CommonStockOtherValueOutstanding`	$5.47M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$318.36M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$488.03M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-42.27M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-35.08M	USD	Point-in-time
Treasury stock, at cost: 13,413 and 12,242 shares in 2016 and 2015, respectively	`TreasuryStockValue`	$1.32B	USD	Point-in-time
Treasury stock, at cost: 13,413 and 12,242 shares in 2016 and 2015, respectively	`TreasuryStockValue`	$1.41B	USD	Point-in-time
Total IDEXX Laboratories, Inc. stockholders equity (deficit)	`StockholdersEquity`	$-84.12M	USD	Point-in-time
Total IDEXX Laboratories, Inc. stockholders equity (deficit)	`StockholdersEquity`	$54.85M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$130.00K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$136.00K	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$54.99M	USD	Point-in-time
Total stockholders equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-84.00M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$1.47B	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$1.50B	USD	Point-in-time

Income Statement 91 line items

Line Item	Tag	Value	Unit	Period
Product revenue	`SalesRevenueGoodsNet`	$730.06M	USD	3 Qtrs
Product revenue	`SalesRevenueGoodsNet`	$800.27M	USD	3 Qtrs
Product revenue	`SalesRevenueGoodsNet`	$246.75M	USD	1 Quarter
Product revenue	`SalesRevenueGoodsNet`	$266.32M	USD	1 Quarter
Service revenue	`SalesRevenueServicesNet`	$472.14M	USD	3 Qtrs
Service revenue	`SalesRevenueServicesNet`	$532.15M	USD	3 Qtrs
Service revenue	`SalesRevenueServicesNet`	$159.64M	USD	1 Quarter
Service revenue	`SalesRevenueServicesNet`	$181.99M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$1.33B	USD	3 Qtrs
Total revenue	`SalesRevenueNet`	$406.39M	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$1.20B	USD	3 Qtrs
Total revenue	`SalesRevenueNet`	$448.31M	USD	1 Quarter
Cost of product revenue	`CostOfGoodsSold`	$92.19M	USD	1 Quarter
Cost of product revenue	`CostOfGoodsSold`	$103.91M	USD	1 Quarter
Cost of product revenue	`CostOfGoodsSold`	$310.45M	USD	3 Qtrs
Cost of product revenue	`CostOfGoodsSold`	$266.76M	USD	3 Qtrs
Cost of service revenue	`CostOfServices`	$97.67M	USD	1 Quarter
Cost of service revenue	`CostOfServices`	$89.93M	USD	1 Quarter
Cost of service revenue	`CostOfServices`	$287.17M	USD	3 Qtrs
Cost of service revenue	`CostOfServices`	$262.87M	USD	3 Qtrs
Total cost of revenue	`CostOfRevenue`	$201.58M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$182.11M	USD	1 Quarter
Total cost of revenue	`CostOfRevenue`	$529.63M	USD	3 Qtrs
Total cost of revenue	`CostOfRevenue`	$597.62M	USD	3 Qtrs
Gross profit	`GrossProfit`	$224.27M	USD	1 Quarter
Gross profit	`GrossProfit`	$246.73M	USD	1 Quarter
Gross profit	`GrossProfit`	$672.58M	USD	3 Qtrs
Gross profit	`GrossProfit`	$734.81M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$236.45M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$73.11M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$79.97M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$223.46M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$46.20M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$156.24M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$133.72M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$52.63M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$74.19M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$24.86M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$25.67M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$75.70M	USD	3 Qtrs
Impairment charge	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$2.23M	USD	3 Qtrs
Impairment charge	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$8.21M	USD	3 Qtrs
Impairment charge	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$8.21M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$88.46M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$266.41M	USD	3 Qtrs
Income from operations	`OperatingIncomeLoss`	$71.89M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$233.00M	USD	3 Qtrs
Interest expense	`InterestExpense`	$7.79M	USD	1 Quarter
Interest expense	`InterestExpense`	$24.29M	USD	3 Qtrs
Interest expense	`InterestExpense`	$21.31M	USD	3 Qtrs
Interest expense	`InterestExpense`	$7.75M	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$684.00K	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$851.00K	USD	1 Quarter
Interest income	`InterestAndOtherIncome`	$1.67M	USD	3 Qtrs
Interest income	`InterestAndOtherIncome`	$2.60M	USD	3 Qtrs
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$213.36M	USD	3 Qtrs
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$64.83M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$244.72M	USD	3 Qtrs
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$81.52M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$65.61M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$75.04M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$25.07M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$20.60M	USD	1 Quarter
Net income	`ProfitLoss`	$147.75M	USD	3 Qtrs
Net income	`ProfitLoss`	$169.68M	USD	3 Qtrs
Net income	`ProfitLoss`	$44.23M	USD	1 Quarter
Net income	`ProfitLoss`	$56.45M	USD	1 Quarter
Less: Net (loss) income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$16.00K	USD	3 Qtrs
Less: Net (loss) income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$7.00K	USD	3 Qtrs
Less: Net (loss) income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-3.00K	USD	1 Quarter
Less: Net (loss) income attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$6.00K	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$56.45M	USD	1 Quarter
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$169.68M	USD	3 Qtrs
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$147.73M	USD	3 Qtrs
Net income attributable to IDEXX Laboratories, Inc. stockholders	`NetIncomeLoss`	$44.22M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.63	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$1.59	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$0.48	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$1.89	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$1.57	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.62	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$1.87	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$0.48	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	93.19M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	91.94M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	89.88M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	89.89M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	94.26M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	90.96M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	91.14M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	92.90M	shares	1 Quarter

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$147.75M	USD	3 Qtrs
Net income	`ProfitLoss`	$169.68M	USD	3 Qtrs
Net income	`ProfitLoss`	$44.23M	USD	1 Quarter
Net income	`ProfitLoss`	$56.45M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$51.23M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$57.98M	USD	3 Qtrs
Amortization on marketable securities, net	`AmortizationOfDebtDiscountPremium`	$967.00K	USD	3 Qtrs
Amortization on marketable securities, net	`AmortizationOfDebtDiscountPremium`	$727.00K	USD	3 Qtrs
Impairment charge	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$2.23M	USD	3 Qtrs
Impairment charge	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$8.21M	USD	3 Qtrs
Impairment charge	`ImpairmentOfLongLivedAssetsToBeDisposedOf`	$8.21M	USD	1 Quarter
Provision for uncollectible accounts	`ProvisionForDoubtfulAccounts`	$1.81M	USD	3 Qtrs
Provision for uncollectible accounts	`ProvisionForDoubtfulAccounts`	$842.00K	USD	3 Qtrs
Provision for (benefit of) deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-4.65M	USD	3 Qtrs
Provision for (benefit of) deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$6.24M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$14.76M	USD	3 Qtrs
Share-based compensation expense	`ShareBasedCompensation`	$15.02M	USD	3 Qtrs
Other	`OtherOperatingActivitiesCashFlowStatement`	$1.16M	USD	3 Qtrs
Other	`OtherOperatingActivitiesCashFlowStatement`	$-305.00K	USD	3 Qtrs
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$10.04M	USD	3 Qtrs
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$10.22M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$16.65M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$51.02M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$27.24M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$2.50M	USD	3 Qtrs
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-8.65M	USD	3 Qtrs
Other assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-16.54M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-2.84M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-2.50M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$3.80M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-2.69M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$142.47M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$234.46M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$67.52M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$49.96M	USD	3 Qtrs
Purchase of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$231.39M	USD	3 Qtrs
Purchase of marketable securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$178.83M	USD	3 Qtrs
Proceeds from the sale and maturities of marketable securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$152.28M	USD	3 Qtrs
Proceeds from the sale and maturities of marketable securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$24.71M	USD	3 Qtrs
Acquisitions of a business, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$8.20M	USD	3 Qtrs
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-76.51M	USD	3 Qtrs
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-282.39M	USD	3 Qtrs
Repayments on revolving credit facilities, net	`ProceedsFromRepaymentsOfOtherDebt`	$-6.50M	USD	3 Qtrs
Repayments on revolving credit facilities, net	`ProceedsFromRepaymentsOfOtherDebt`	$-85.00M	USD	3 Qtrs
Debt issue costs	`PaymentsOfDebtIssuanceCosts`	$199.00K	USD	3 Qtrs
Debt issue costs	`PaymentsOfDebtIssuanceCosts`	$57.00K	USD	3 Qtrs
Issuance of long term debt	`ProceedsFromIssuanceOfLongTermDebt`	$250.10M	USD	3 Qtrs
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$91.56M	USD	3 Qtrs
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$309.06M	USD	3 Qtrs
Proceeds from exercises of stock options and employee stock purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$28.82M	USD	3 Qtrs
Proceeds from exercises of stock options and employee stock purchase plans	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$19.22M	USD	3 Qtrs
Payment of acquisition-related contingent consideration	`PaymentsOfMergerRelatedCostsFinancingActivities`	$3.63M	USD	3 Qtrs
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$10.04M	USD	3 Qtrs
Tax benefit from share-based compensation arrangements	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$10.22M	USD	3 Qtrs
Net cash used by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-141.21M	USD	3 Qtrs
Net cash used by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-36.39M	USD	3 Qtrs
Net effect of changes in exchange rates on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$4.34M	USD	3 Qtrs
Net effect of changes in exchange rates on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-5.07M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$21.08M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-181.39M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$150.07M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$141.15M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$128.99M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$322.54M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$150.07M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$141.15M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$128.99M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$322.54M	USD	Point-in-time

Comprehensive Income 56 line items

Line Item	Tag	Value	Unit	Period
Unrealized gain (loss) on investments, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$-60.00K	USD	1 Quarter
Unrealized gain (loss) on investments, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$19.00K	USD	1 Quarter
Net income	`ProfitLoss`	$147.75M	USD	3 Qtrs
Net income	`ProfitLoss`	$169.68M	USD	3 Qtrs
Unrealized gain (loss) on investments, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$134.00K	USD	3 Qtrs
Unrealized gain (loss) on investments, tax expense (benefit)	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax`	$-29.00K	USD	3 Qtrs
Net income	`ProfitLoss`	$44.23M	USD	1 Quarter
Net income	`ProfitLoss`	$56.45M	USD	1 Quarter
Unrealized (loss) gain, net of tax (benefit) expense	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$2.88M	USD	3 Qtrs
Unrealized (loss) gain, net of tax (benefit) expense	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$-57.00K	USD	1 Quarter
Unrealized (loss) gain, net of tax (benefit) expense	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$1.03M	USD	1 Quarter
Unrealized (loss) gain, net of tax (benefit) expense	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax`	$-694.00K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-26.79M	USD	3 Qtrs
Reclassification adjustment for gains included in net income, tax expense	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax`	$-4.08M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$10.87M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-13.86M	USD	1 Quarter
Reclassification adjustment for gains included in net income, tax expense	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax`	$-1.37M	USD	1 Quarter
Reclassification adjustment for gains included in net income, tax expense	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax`	$-197.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$1.69M	USD	1 Quarter
Reclassification adjustment for gains included in net income, tax expense	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax`	$-313.00K	USD	3 Qtrs
Unrealized (loss) gain on net investment hedge	`TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax`	$340.00K	USD	3 Qtrs
Unrealized (loss) gain on net investment hedge	`TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax`	$-1.65M	USD	3 Qtrs
Unrealized (loss) gain on net investment hedge	`TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax`	$-396.00K	USD	1 Quarter
Unrealized (loss) gain on net investment hedge	`TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax`	$-732.00K	USD	1 Quarter
Unrealized gain (loss) on investments, net of tax expense of $19 and $134 in 2016 and( $60) and ($29) in 2015	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-88.00K	USD	1 Quarter
Unrealized gain (loss) on investments, net of tax expense of $19 and $134 in 2016 and( $60) and ($29) in 2015	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-81.00K	USD	3 Qtrs
Unrealized gain (loss) on investments, net of tax expense of $19 and $134 in 2016 and( $60) and ($29) in 2015	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$9.00K	USD	1 Quarter
Unrealized gain (loss) on investments, net of tax expense of $19 and $134 in 2016 and( $60) and ($29) in 2015	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$334.00K	USD	3 Qtrs
Unrealized (loss) gain, net of tax (benefit) expense of ($57) and ($694) in 2016 and $1,030 and $2,882 in 2015	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$-129.00K	USD	1 Quarter
Unrealized (loss) gain, net of tax (benefit) expense of ($57) and ($694) in 2016 and $1,030 and $2,882 in 2015	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$2.50M	USD	1 Quarter
Unrealized (loss) gain, net of tax (benefit) expense of ($57) and ($694) in 2016 and $1,030 and $2,882 in 2015	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$-1.57M	USD	3 Qtrs
Unrealized (loss) gain, net of tax (benefit) expense of ($57) and ($694) in 2016 and $1,030 and $2,882 in 2015	`OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax`	$6.79M	USD	3 Qtrs
Less: reclassification adjustment for gains included in net income, net of tax expense of ($198) and ($313) in 2016 and ($1,374) and ($4,079) in 2015	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax`	$451.00K	USD	1 Quarter
Less: reclassification adjustment for gains included in net income, net of tax expense of ($198) and ($313) in 2016 and ($1,374) and ($4,079) in 2015	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax`	$3.37M	USD	1 Quarter
Less: reclassification adjustment for gains included in net income, net of tax expense of ($198) and ($313) in 2016 and ($1,374) and ($4,079) in 2015	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax`	$9.68M	USD	3 Qtrs
Less: reclassification adjustment for gains included in net income, net of tax expense of ($198) and ($313) in 2016 and ($1,374) and ($4,079) in 2015	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax`	$804.00K	USD	3 Qtrs
Unrealized loss on derivative instruments	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-874.00K	USD	1 Quarter
Unrealized loss on derivative instruments	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-2.37M	USD	3 Qtrs
Unrealized loss on derivative instruments	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-580.00K	USD	1 Quarter
Unrealized loss on derivative instruments	`OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax`	$-2.89M	USD	3 Qtrs
Other comprehensive gain (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$384.00K	USD	1 Quarter
Other comprehensive gain (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-15.22M	USD	1 Quarter
Other comprehensive gain (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$7.18M	USD	3 Qtrs
Other comprehensive gain (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTax`	$-29.42M	USD	3 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$29.01M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$176.87M	USD	3 Qtrs
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$56.84M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$118.32M	USD	3 Qtrs
Less: comprehensive (loss) income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$6.00K	USD	1 Quarter
Less: comprehensive (loss) income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$7.00K	USD	3 Qtrs
Less: comprehensive (loss) income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$16.00K	USD	3 Qtrs
Less: comprehensive (loss) income attributable to noncontrolling interest	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$-3.00K	USD	1 Quarter
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$176.86M	USD	3 Qtrs
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$118.31M	USD	3 Qtrs
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$29.01M	USD	1 Quarter
Comprehensive income attributable to IDEXX Laboratories, Inc.	`ComprehensiveIncomeNetOfTax`	$56.84M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.